syringe for tirzepatide Injection Vial Weight Management Stock Illustration 2770262929 Lilly releases Zepbound® (tirzepatide) single-dose

Current research suggests these symptoms usually relate to: Reduced calorie intake Mild dehydration Nausea Changes in sleep patterns during the early treatment period There is no evidence that semaglutide directly harms cognitive function or causes neurological damage

So far, though, universities and federal agencies are leading the charge in this space

Still, Srivastava cautions against treating those averages as guarantees

Many patients report that gastrointestinal symptoms tend to improve over time as the body adapts to the medication

Unlike sedatives, it helps maintain the natural sleep cycle without suppression (1)

Key Risk Factors for Blood Clots During GLP-1 Weight Loss Therapy Certain conditions and lifestyle factors increase thrombotic risk and merit special consideration before starting semaglutide